Sanofi SA (NASDAQ:SNY)
| 49.37 Delayed Data As of Jan 15 |  +0.34 / +0.69%Today’s Change | 37.62 Today|||52-Week Range 55.00 | +1.61% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2015 | Quarter 3 2015 | Quarter 4 2015 | Quarter 1 2016 | |||
| Revenue and Income | Net Revenues | 10.4B | 10.7B | 9.4B | 8.6B | |
| Cost of Goods Sold | 3.3B | 3.3B | 3.1B | 2.7B | ||
| Depreciation And Amortization | 678.4M | 666.1M | 752.2M | 489.6M | ||
| Operating Expenses | Gross Income | 6.5B | 6.7B | 5.6B | 5.4B | |
| General Expenses | 4.4B | 4.3B | 4.2B | 3.8B | ||
| Other Operating Expenses | 74.4M | 31.2M | 131.0M | 136.7M | ||
| Research And Development | 1.4B | 1.5B | 1.5B | 1.4B | ||
| Total Operating Expenses | 8.4B | 8.3B | 8.1B | 7.1B | ||
| Non-Operating Expenses | Operating Income | 2.0B | 2.4B | 1.3B | 1.5B | |
| Extraordinary Credit | 77.7M | 100.2M | 0.00 | 0.00 | ||
| Extraordinary Charge | -32.2M | -297.4M | -1.1B | -583.3M | ||
| Interest Expense On Debt | 148.8M | 141.5M | 186.2M | 142.3M | ||
| Equity In Earnings | -38.9M | 81.3M | -30.3M | 102.6M | ||
| Other Expenses | 168.8M | 3.3M | 264.1M | 399.2M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 2.1B | 2.1B | 392.9M | 1.1B | |
| Income Taxes | -576.3M | -303.0M | -236.0M | -129.0M | ||
| Minority Interest | -30.0M | -25.6M | -20.6M | -28.7M | ||
| Discontinued Operations | 0.00 | 0.00 | -216.5M | 110.3M | ||
| Net Income | 1.4B | 1.8B | 361.5M | 1.2B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.6B | 2.6B | 2.6B | 2.6B | |
| Shares To Calculate EPS Diluted | -- | -- | -- | -- | -- | |
| Earnings Per Share | EPS | $0.56 | $0.70 | $0.14 | $0.46 | |
| EPS Diluted | $0.55 | $0.69 | -- | -- | ||
